Zelluna Immunotherapy Alternatives & Competitors
12 companies similar to Zelluna Immunotherapy — Developing allogeneic TCR-NK therapies for solid tumors
Companies similar to Zelluna Immunotherapy
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
Alaunos Therapeutics
Attacking solid tumors with TCRs
Houston, United States
3T Biosciences
3T is an immunotherapy company developing next-generation, transformative therapies for br...
South San Francisco, Unit...
GammaDelta Therapeutics
GammaDelta Therapeutics focuses on using γδ T cells to improve survival rates of patients...
London, United Kingdom
Track all Zelluna Immunotherapy competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Adicet Bio, Inc
A biotechnology company discovering and developing first-in-class allogeneic gamma delta C...
Redwood City, United Stat...
MetiMedi Co., Ltd.
MetiMedi is developing a first-in-class oral immunotherapeutic small molecule in Phase 2 f...
Korea South
Carisma Therapeutics
Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors
Philadelphia, United Stat...
MedGene Therapeutics, Inc.
Better life through better science. MedGene Therapeutics, Inc. is a T cell therapy biote...
Gaithersburg, United Stat...
Affini-T Therapeutics
Right Targets. Right Cells. Right Place. Unlocking the power of T cells against oncogenic...
Watertown, United States
Adaptimmune
Designing and delivering cell therapies to transform the lives of people with cancer.
Abingdon, United Kingdom
Brenus Pharma
Next-generation cancer treatment bringing the immune system one step ahead of cancer 🧬🟣
Lyon, France
Gracell Biotechnologies
A Member of the AstraZeneca Group
Shanghai, China
About Zelluna Immunotherapy
Zelluna is a Norway-based biotechnology company founded in 2016. The company is focused on pioneering allogeneic T cell receptor (TCR) guided natural killer (NK) cell immunotherapies for the treatment of solid cancers. Zelluna's slogan "Developing allogeneic TCR-NK therapies for solid tumors" encapsulates its mission.
Immunotherapy, Cancer Treatment, Adoptive Cell Therapy, T Cell Receptor Technologies, Solid Tumors, Biopharmaceutical, Cellular Therapy, Allogeneic TCR-NK Therapies, GMP Facilities, Oslo Cancer Cluster, Norwegian Radium Hospital, Research And Development, Immunooncology, Norwegian Biotechnology
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Zelluna Immunotherapy and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Zelluna Immunotherapy on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
